Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bioxcel Therapeutics Inc.

2.95
+0.25009.26%
Volume:9.55M
Turnover:29.25M
Market Cap:9.15M
PE:-0.09
High:3.36
Open:3.20
Low:2.82
Close:2.70
Loading ...

BioXcel Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Rule

GlobeNewswire
·
28 Feb

BioXcel to Implement Reverse Stock Split; Shares Fall

MT Newswires Live
·
07 Feb

BioXcel Therapeutics Announces Reverse Stock Split

THOMSON REUTERS
·
06 Feb

BioXcel Therapeutics Inc - to Effect 1-for-16 Reverse Stock Split

THOMSON REUTERS
·
06 Feb

BioXcel Therapeutics Announces Reverse Stock Split

GlobeNewswire
·
06 Feb

BioXcel Therapeutics Provides Clinical and Business Update

THOMSON REUTERS
·
05 Feb

BRIEF-BioXcel Therapeutics Increases Board Size To Eight Directors

Reuters
·
16 Jan

BioXcel Therapeutics Inc - Increases Board Size to Eight Directors

THOMSON REUTERS
·
16 Jan

BioXcel Therapeutics files to sell 5.1M shares of common stock for holders

TIPRANKS
·
11 Jan

BioXcel Therapeutics Inc Files for Resale of up to 5.1 Mln Shares by the Selling Stockholders - SEC Filing

THOMSON REUTERS
·
11 Jan

BofA Securities Downgrades BioXcel Therapeutics to Underperform From Buy, Adjusts Price Target to $0.25 From $7

MT Newswires Live
·
07 Jan

BioXcel Therapeutics Inc : Bofa Global Research Cuts to Underperform From Buy; Cuts Price Objective to $0.25 From $7

THOMSON REUTERS
·
07 Jan

BioXcel Therapeutics (BTAI) Moves to Buy: Rationale Behind the Upgrade

Zacks
·
24 Dec 2024

BioXcel Therapeutics announces pricing of $7M public offering

seekingalpha
·
22 Nov 2024

BioXcel Therapeutics prices 5.6M shares at 48c in public offering

TIPRANKS
·
22 Nov 2024

BioXcel Therapeutics Announces Pricing of $7.0 Million Public Offering

THOMSON REUTERS
·
22 Nov 2024